Free Trial

Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of "Buy" by Analysts

Privia Health Group logo with Medical background
Remove Ads

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) has been assigned an average rating of "Buy" from the sixteen brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, thirteen have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $26.67.

PRVA has been the topic of a number of research reports. Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Stephens reiterated an "overweight" rating and issued a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a report on Friday, November 29th. JMP Securities set a $29.00 price objective on Privia Health Group in a report on Friday, February 28th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a research report on Friday, March 21st.

View Our Latest Analysis on PRVA

Hedge Funds Weigh In On Privia Health Group

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. increased its holdings in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after purchasing an additional 632 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after acquiring an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. acquired a new stake in shares of Privia Health Group in the fourth quarter worth $51,000. Quarry LP raised its holdings in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after purchasing an additional 2,533 shares during the last quarter. Finally, KBC Group NV raised its holdings in shares of Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company's stock worth $62,000 after purchasing an additional 871 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.

Remove Ads

Privia Health Group Stock Up 0.2 %

PRVA stock traded up $0.04 during midday trading on Monday, hitting $22.92. The company's stock had a trading volume of 892,334 shares, compared to its average volume of 754,513. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $26.04. The company has a 50 day moving average of $23.77 and a two-hundred day moving average of $21.12. The firm has a market capitalization of $2.76 billion, a price-to-earnings ratio of 229.22, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85.

About Privia Health Group

(Get Free Report

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads